(Q45831311)

English

Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Jun Miyoshi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Katsuyoshi Matsuoka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Nagamu Inoue

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tadakazu Hisamatsu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Riko Ichikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tomoharu Yajima

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Susumu Okamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Makoto Naganuma

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Toshiro Sato

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Haruhiko Ogata

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yasushi Iwao

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Journal of Crohn's and Colitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

e609-14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23680174%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.018

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45831311&oldid=1627403126"